ClinicalTrials.govpublic full text
Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
hepatocellular carcinoma, argininosuccinate synthetase, arginine, arginine deiminase, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837799
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.